News

Mark B. DeSanto Elevated to Shareholder at Berger Montague

Mark B. DeSanto Elevated to Shareholder at Berger Montague

Mark B. DeSanto Promoted to Shareholder at Berger Montague

Berger Montague, a leading law firm that advocates for consumers, is excited to announce the promotion of Mark B. DeSanto to Shareholder. This new position reflects both his dedication and exemplary contributions to the firm over the years.

Mark expressed his enthusiasm about the new role, stating, "Joining the ranks of some of the most talented advocates in the country is thrilling. I eagerly anticipate contributing to the firm’s continued success in securing justice for our clients nationwide." His passion for helping individuals and small businesses has defined his career and underscores his commitment to the firm and its mission.

Leadership's Praise for DeSanto

Eric L. Cramer, the Firm Chairman, voiced his excitement regarding Mark's elevation within the firm, saying, "Mark is a passionate advocate for our clients and a top-notch litigator. We are delighted to welcome him to our talented shareholder ranks and are eager to see his future accomplishments." This kind of support from leadership indicates a strong belief in Mark's abilities and potential.

Mark B. DeSanto's Professional Background

With over 11 years of specialized experience, Mr. DeSanto focuses on data privacy and consumer litigation. His track record includes significant involvement in class action suits, where he has played a crucial role in securing recoveries exceeding $350 million for class members in just one year.

Mark has been instrumental in several high-profile data breach lawsuits. Notably, his work includes major cases like a data breach impacting over 90 million consumers, showcasing his capabilities in addressing complex legal challenges. His numerous appointments to lead counsel positions highlight his expertise and reputation in the field.

Major Legal Cases and Contributions

Among the significant cases under his belt are the MOVEit Customer Data Security Breach and the Change Healthcare Data Security Breach litigation, which affected millions of individuals and countless healthcare providers. His leadership in these cases demonstrates his skillful navigation through the intricacies of legal proceedings associated with data breaches.

The Legacy of Berger Montague

Founded over 50 years ago, Berger Montague has established itself as a prominent force in civil litigation, known for tackling complex cases in class actions and mass torts across various jurisdictions. The firm’s focus encompasses a wide range of legal fields, including consumer protection, commercial litigation, antitrust, and employment law.

Berger Montague has consistently been at the forefront of precedent-setting legal battles, having recovered over $50 billion for clients. The firm fosters a strong culture of advocacy and integrity, making it a destination for clients in need of exceptional legal services.

A Bright Future Ahead

As Mark embarks on this new chapter as a Shareholder, he is set to further enhance the firm's reputation as an advocate for consumers and businesses alike. His extensive experience in litigation and sincere passion for seeking justice for clients paints a promising picture of the future at Berger Montague.

Frequently Asked Questions

What position has Mark B. DeSanto been promoted to?

Mark B. DeSanto has been elevated to Shareholder at Berger Montague.

What is Mark B. DeSanto's area of expertise?

Mark specializes in data privacy and consumer litigation.

How much has Mr. DeSanto recovered in class actions?

He has helped recover over $350 million for class members across various cases.

What notable cases has Mark been involved in?

Mark has worked on major cases including the MOVEit Customer Data Security Breach and Change Healthcare Data Security Breach litigation.

How long has Berger Montague been in operation?

Berger Montague has been operating for over 50 years, focusing on complex civil litigation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading